Please, Signup (Login) to subscribe or trade (demo)
Allergan plc. stock price
Allergan plc. latest news:
Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product
Allergan PLC(AGN) shares rose 1.8% in heavy Friday afternoon trade on news of an unorthodox agreement the company has made with the Saint Regis Mohawk Tribe that could protect patents on a key Allergan (AGN) dry eye product, Restasis. Under the agreement, the Saint Regis Mohawk Tribe now owns patents on Restasis-- which are expected to expire at the end of August 2024-- and has granted Allergan (AGN) exclusive licenses on the product. The Saint Regis Mohawk Tribe is filing to dismiss patent challenges...
BRIEF-Allergan USA files suits against Imprimis, Prescriber's Choice and Sincerus Florida
Allergan Plc(AGN). * Allergan(AGN) files suits against Imprimis Pharmaceuticals, Inc. (IMMY), Prescriber's Choice, Inc., and Sincerus Florida, LLC. * Says Allergan USA filed lawsuits against Imprimis Pharmaceuticals (IMMY), Prescriber's Choice, and Sincerus Florida. * Allergan USA's lawsuit alleges that the companies are unlawfully manufacturing and selling unapproved new drugs.
Sarepta Therapeutics names new CEO
Drugmaker Sarepta Therapeutics Inc. on Wednesday named Douglas Ingram its next chief executive. Ingram, currently the president and CEO at Allergan PLC's Chase Pharmaceutics, will start Sept. 20, Sarepta said. He replaces Edward Kaye, who took over as interim chief executive in 2015. Last year, Sarepta won government approval for its Duchenne muscular dystrophy drug.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Alliance California Municipal Income Fund IncAKP
Alliance Data Systems CorporationADS
Alliance National Municipal Income Fund IncAFB
Alliance One InternationalAOI
Alliance World Dollar Government Fund IIAWF
ALLIANCEBERNSTEIN INCOME FUND INCACG
Allianceberstein Holding L.P.AB
Alliant Energy CorporationLNT